- Home
- PHAR vs EQBK Comparison
PHAR vs EQBK Comparison
Compare PHAR & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- EQBK
- Stock Information
- Founded
- PHAR 1988
- EQBK 2002
- Country
- PHAR Netherlands
- EQBK United States
- Employees
- PHAR N/A
- EQBK N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- PHAR Health Care
- EQBK Finance
- Exchange
- PHAR Nasdaq
- EQBK Nasdaq
- Market Cap
- PHAR 627.5M
- EQBK 619.4M
- IPO Year
- PHAR N/A
- EQBK 2015
- Fundamental
- Price
- PHAR $8.18
- EQBK $47.19
- Analyst Decision
- PHAR Strong Buy
- EQBK Hold
- Analyst Count
- PHAR 2
- EQBK 4
- Target Price
- PHAR $33.50
- EQBK $42.75
- AVG Volume (30 Days)
- PHAR 6.6K
- EQBK 46.8K
- Earning Date
- PHAR 10-24-2024
- EQBK 10-15-2024
- Dividend Yield
- PHAR N/A
- EQBK 1.27%
- EPS Growth
- PHAR N/A
- EQBK N/A
- EPS
- PHAR N/A
- EQBK 1.12
- Revenue
- PHAR $285,745,000.00
- EQBK $157,755,000.00
- Revenue This Year
- PHAR $20.89
- EQBK N/A
- Revenue Next Year
- PHAR $11.15
- EQBK $4.73
- P/E Ratio
- PHAR N/A
- EQBK $42.10
- Revenue Growth
- PHAR 30.64
- EQBK N/A
- 52 Week Low
- PHAR $6.65
- EQBK $24.92
- 52 Week High
- PHAR $13.20
- EQBK $48.61
- Technical
- Relative Strength Index (RSI)
- PHAR 47.63
- EQBK 64.62
- Support Level
- PHAR $7.70
- EQBK $47.04
- Resistance Level
- PHAR $8.28
- EQBK $48.61
- Average True Range (ATR)
- PHAR 0.41
- EQBK 1.26
- MACD
- PHAR -0.07
- EQBK 0.28
- Stochastic Oscillator
- PHAR 44.27
- EQBK 80.06
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.